Perrigo Company plc (PRGO) Stock

NYSE: PRGOGlobal consumer self-care company offering over-the-counter health and wellness solutions.

Perrigo stock price chart

PRGO stock quote & key statistics

Perrigo earnings per share

Income →
Earnings per share

Perrigo revenue & net income

Income →
RevenueNet income

Perrigo annual financials

Income statement →
Perrigo Company plc revenue, net income and EPS by fiscal year
Fiscal yearRevenueNet incomeEPS
FY2025$4.25B-$1.43B$2.74
FY2024$4.37B-$171.8M$1.99
FY2023$4.66B-$12.7M$2.58
FY2022$4.45B-$140.6M$2.07
FY2021$4.14B-$68.9M$2.05

Fiscal year ending December 31. Source: company filings via EODHD.

About Perrigo Company plc

Perrigo Company plc specializes in providing over-the-counter (OTC) health and wellness solutions that empower individuals to manage and enhance their well-being through self-care. The company operates across two key segments: Consumer Self-Care Americas and Consumer Self-Care International. In the Americas, Perrigo focuses on developing, manufacturing, marketing, and selling store brand products in diverse categories such as upper respiratory health, pain relief, sleep aids, digestive health, nutrition, vitamins, supplements, skincare, personal hygiene, and oral care. These products are marketed under well-known brand names including Prevacid 24HR, Good Sense, Zephrex D, ScarAway, Plackers, Rembrandt, Steripod, Firefly, REACH, Dr. Fresh, and Burt's Bees.

Internationally, through its Consumer Self-Care International segment, Perrigo extends its reach across approximately 23 countries in Europe and other regions. It leverages a robust network of pharmacies, wholesalers, drugstores, grocery retailers, and para-pharmacies to distribute its portfolio of consumer self-care brands. The company's international operations encompass the development, manufacturing, marketing, and distribution of OTC products tailored to meet the diverse health and wellness needs of consumers globally.

In addition to its core business activities, Perrigo also offers contract manufacturing services, enhancing its role as a trusted partner in the broader healthcare industry. With a legacy dating back to 1887, Perrigo has continually evolved to meet changing consumer needs and healthcare trends, maintaining its commitment to providing accessible and effective self-care solutions. Headquartered in Dublin, Ireland, Perrigo Company plc remains dedicated to advancing individual health outcomes through innovation and quality in its product offerings.

Perrigo stock FAQ

What is the Perrigo stock ticker symbol?

Perrigo Company plc trades on the NYSE under the ticker symbol PRGO.

What sector and industry is Perrigo in?

Perrigo Company plc is classified in the Healthcare sector, Drug Manufacturers - Specialty & Generic industry.

How many employees does Perrigo have?

Perrigo Company plc has about 8,100 full-time employees.

What were Perrigo's revenue and earnings last fiscal year?

Perrigo reported revenue of $4.25B and net income of -$1.43B in fiscal 2025, with earnings per share of $2.74. Revenue declined 2.8% from the prior year.

Is Perrigo in the S&P SmallCap 600?

Yes. Perrigo Company plc (PRGO) is a component of the S&P SmallCap 600, the benchmark index of profitable U.S. small-cap stocks.

Is Perrigo in the Russell 2000?

Yes. Perrigo Company plc (PRGO) is a component of the Russell 2000, the benchmark index of U.S. small-cap stocks.

When did Perrigo go public?

Perrigo stock began trading on December 16, 1991.

S&P SmallCap 600 Healthcare stocks

All S&P SmallCap 600 →